Enhanced Genomics

Cambridge, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a biotechnology platform designed to develop tools for large-scale analysis of genetic variations and gene function. Enhanced Genomics is based in Cambridge, United Kingdom and was founded in 2020. Its last reported valuation was $28.1 million in Sep 2025. It has raised $21.8 million.

Last reported valuation
$28.1M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—

Who backs Enhanced Genomics?

9 investors
InvestorType
BGF (Financial Services)Growth equity
Parkwalk AdvisorsVenture capital
Meltwind Advisory—
Jonathan Milner—
Vincent TchenguizOther
Accelerate@Babraham—
Bioqube Ventures—
Frame Shift Bio-Incubator—
Start Codon—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Enhanced Genomics investors

9 investors are on record for Enhanced Genomics, including BGF (Financial Services), Parkwalk Advisors, Meltwind Advisory and Jonathan Milner.

Free account
More of Enhanced Genomics with a free account
  • ·Watch Enhanced Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Enhanced Genomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View